NewEdge Advisors’s Vaxart VXRT Stock Holding History

NewEdge Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	–	–	4171
2025 Q1	$0	Hold	1	–	–	﹤0.01%	4118
2024 Q4	$1	Sell	1 -443	-100%	-$308	﹤0.01%	3897
2024 Q3	$377	Buy	+444	New	+$339	﹤0.01%	3633

Other funds holding VXRT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

NewEdge Advisors's VXRT Position: Q2 2025 in Review

NewEdge Advisors sold out of Vaxart (VXRT) in Q2 2025, closing a stake of 1 share.

NewEdge Advisors first reported a position in VXRT in Q3 2024 and held it in 3 quarters. The position peaked at $377 in Q3 2024. 98 funds tracked by Wall St. Rank hold VXRT as of Q2 2025.

NewEdge Advisors reported no remaining Vaxart position as of Q2 2025 after selling out during the quarter.
NewEdge Advisors sold 1 Vaxart share in Q2 2025.
NewEdge Advisors first reported a position in Vaxart in Q3 2024 and held it in 3 quarters.
NewEdge Advisors's Vaxart position peaked at $377 in Q3 2024.
98 funds tracked by Wall St. Rank held Vaxart as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.